nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4C—tongue—Parkinson's disease	0.0603	0.21	CbGeAlD
Roflumilast—PDE4C—brainstem—Parkinson's disease	0.0265	0.0922	CbGeAlD
Roflumilast—PDE4C—forebrain—Parkinson's disease	0.0256	0.089	CbGeAlD
Roflumilast—PDE4C—midbrain—Parkinson's disease	0.0169	0.0587	CbGeAlD
Roflumilast—PDE4C—head—Parkinson's disease	0.0146	0.0509	CbGeAlD
Roflumilast—PDE4C—nervous system—Parkinson's disease	0.0139	0.0483	CbGeAlD
Roflumilast—PDE4C—central nervous system—Parkinson's disease	0.0134	0.0465	CbGeAlD
Roflumilast—PDE4B—forebrain—Parkinson's disease	0.0119	0.0413	CbGeAlD
Roflumilast—PDE4D—cerebellum—Parkinson's disease	0.0115	0.04	CbGeAlD
Roflumilast—PDE4C—brain—Parkinson's disease	0.0106	0.0369	CbGeAlD
Roflumilast—PDE4A—cerebellum—Parkinson's disease	0.0102	0.0354	CbGeAlD
Roflumilast—PDE4D—brain—Parkinson's disease	0.00934	0.0325	CbGeAlD
Roflumilast—PDE4B—medulla oblongata—Parkinson's disease	0.00858	0.0299	CbGeAlD
Roflumilast—PDE4A—brain—Parkinson's disease	0.00827	0.0288	CbGeAlD
Roflumilast—PDE4B—midbrain—Parkinson's disease	0.00785	0.0273	CbGeAlD
Roflumilast—PDE4B—spinal cord—Parkinson's disease	0.00765	0.0266	CbGeAlD
Roflumilast—PDE4B—head—Parkinson's disease	0.0068	0.0237	CbGeAlD
Roflumilast—PDE4B—nervous system—Parkinson's disease	0.00645	0.0224	CbGeAlD
Roflumilast—PDE4B—central nervous system—Parkinson's disease	0.00621	0.0216	CbGeAlD
Roflumilast—PDE4B—cerebellum—Parkinson's disease	0.00607	0.0211	CbGeAlD
Roflumilast—PDE4B—brain—Parkinson's disease	0.00493	0.0171	CbGeAlD
Roflumilast—PDE4C—GPCR downstream signaling—PDYN—Parkinson's disease	0.00191	0.00268	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PENK—Parkinson's disease	0.00189	0.00266	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GRK5—Parkinson's disease	0.00188	0.00264	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GRK5—Parkinson's disease	0.00184	0.00259	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VPS35—Parkinson's disease	0.00182	0.00256	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GRM4—Parkinson's disease	0.00182	0.00256	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PENK—Parkinson's disease	0.00181	0.00255	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—GRM5—Parkinson's disease	0.00177	0.00249	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GRM4—Parkinson's disease	0.00174	0.00244	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DGKQ—Parkinson's disease	0.00174	0.00244	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VPS35—Parkinson's disease	0.00174	0.00244	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GPR37—Parkinson's disease	0.00174	0.00244	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PDYN—Parkinson's disease	0.00173	0.00243	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PENK—Parkinson's disease	0.00173	0.00242	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GRK5—Parkinson's disease	0.00171	0.0024	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GRM4—Parkinson's disease	0.00169	0.00237	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PDYN—Parkinson's disease	0.00166	0.00233	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GRM4—Parkinson's disease	0.00165	0.00232	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PENK—Parkinson's disease	0.00165	0.00231	CbGpPWpGaD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—IL1B—Parkinson's disease	0.00163	0.00229	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—GRM5—Parkinson's disease	0.00161	0.00226	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VPS35—Parkinson's disease	0.00161	0.00225	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PENK—Parkinson's disease	0.0016	0.00224	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00159	0.00223	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PDYN—Parkinson's disease	0.00158	0.00222	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PENK—Parkinson's disease	0.00157	0.0022	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—GRM5—Parkinson's disease	0.00154	0.00217	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GRM4—Parkinson's disease	0.00153	0.00215	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GPR37—Parkinson's disease	0.00151	0.00212	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DGKQ—Parkinson's disease	0.00151	0.00212	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PDYN—Parkinson's disease	0.00151	0.00212	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00151	0.00212	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GRM5—Parkinson's disease	0.00147	0.00206	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PDYN—Parkinson's disease	0.00146	0.00205	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PENK—Parkinson's disease	0.00145	0.00204	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DGKQ—Parkinson's disease	0.00144	0.00202	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GPR37—Parkinson's disease	0.00144	0.00202	CbGpPWpGaD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—IL1B—Parkinson's disease	0.00144	0.00201	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PDYN—Parkinson's disease	0.00143	0.00201	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GRM5—Parkinson's disease	0.0014	0.00197	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RIT2—Parkinson's disease	0.00139	0.00195	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00138	0.00194	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00137	0.00192	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GRM5—Parkinson's disease	0.00136	0.00191	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GRM5—Parkinson's disease	0.00133	0.00187	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DGKQ—Parkinson's disease	0.00133	0.00187	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GPR37—Parkinson's disease	0.00133	0.00187	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PDYN—Parkinson's disease	0.00133	0.00186	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00132	0.00185	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GRK5—Parkinson's disease	0.00132	0.00185	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00131	0.00184	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00131	0.00184	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—TAC1—Parkinson's disease	0.00129	0.00181	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—DRD1—Parkinson's disease	0.00126	0.00177	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00125	0.00175	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GRM5—Parkinson's disease	0.00123	0.00173	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—DRD3—Parkinson's disease	0.00122	0.00172	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00122	0.00171	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RIT2—Parkinson's disease	0.00121	0.0017	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00119	0.00167	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HTR1A—Parkinson's disease	0.00119	0.00167	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GRM4—Parkinson's disease	0.00118	0.00166	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—TAC1—Parkinson's disease	0.00117	0.00164	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00116	0.00162	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RIT2—Parkinson's disease	0.00115	0.00161	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—DRD1—Parkinson's disease	0.00115	0.00161	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GRK5—Parkinson's disease	0.00115	0.00161	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00114	0.0016	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00114	0.0016	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00113	0.00159	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—TAC1—Parkinson's disease	0.00112	0.00157	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAG—Parkinson's disease	0.00112	0.00157	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PENK—Parkinson's disease	0.00112	0.00157	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—DRD3—Parkinson's disease	0.00111	0.00156	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—DRD2—Parkinson's disease	0.00111	0.00155	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HTR7—Parkinson's disease	0.00111	0.00155	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—DRD1—Parkinson's disease	0.0011	0.00154	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GRK5—Parkinson's disease	0.00109	0.00153	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00108	0.00152	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—TAC1—Parkinson's disease	0.00107	0.0015	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—DRD3—Parkinson's disease	0.00106	0.00149	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RIT2—Parkinson's disease	0.00106	0.00149	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00105	0.00147	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—DRD1—Parkinson's disease	0.00105	0.00147	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00104	0.00146	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HTR1A—Parkinson's disease	0.00103	0.00145	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GRM4—Parkinson's disease	0.00103	0.00144	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PDYN—Parkinson's disease	0.00102	0.00144	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—TAC1—Parkinson's disease	0.00102	0.00143	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—DRD3—Parkinson's disease	0.00101	0.00142	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GRK5—Parkinson's disease	0.00101	0.00142	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—DRD2—Parkinson's disease	0.001	0.00141	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HTR7—Parkinson's disease	0.001	0.00141	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HTR1A—Parkinson's disease	0.001	0.00141	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—DRD1—Parkinson's disease	0.000999	0.0014	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000994	0.0014	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—TAC1—Parkinson's disease	0.000988	0.00139	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HTR1A—Parkinson's disease	0.000984	0.00138	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GRM4—Parkinson's disease	0.000978	0.00137	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PENK—Parkinson's disease	0.000974	0.00137	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAG—Parkinson's disease	0.000974	0.00137	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—TAC1—Parkinson's disease	0.000969	0.00136	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—DRD1—Parkinson's disease	0.000968	0.00136	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—DRD3—Parkinson's disease	0.000967	0.00136	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—DRD2—Parkinson's disease	0.000963	0.00135	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HTR7—Parkinson's disease	0.000963	0.00135	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GFAP—Parkinson's disease	0.000962	0.00135	CbGpPWpGaD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—Parkinson's disease	0.000954	0.00134	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GRM5—Parkinson's disease	0.000951	0.00133	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—DRD1—Parkinson's disease	0.00095	0.00133	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000947	0.00133	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—DRD3—Parkinson's disease	0.000938	0.00132	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PENK—Parkinson's disease	0.000927	0.0013	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAG—Parkinson's disease	0.000927	0.0013	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—DRD3—Parkinson's disease	0.000921	0.00129	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—DRD2—Parkinson's disease	0.000917	0.00129	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HTR7—Parkinson's disease	0.000917	0.00129	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HTR1A—Parkinson's disease	0.000911	0.00128	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GRM4—Parkinson's disease	0.000905	0.00127	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000903	0.00127	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—TAC1—Parkinson's disease	0.000897	0.00126	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PDYN—Parkinson's disease	0.00089	0.00125	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—EDN1—Parkinson's disease	0.000886	0.00124	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—DRD1—Parkinson's disease	0.000879	0.00123	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000876	0.00123	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—DRD2—Parkinson's disease	0.000875	0.00123	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HTR7—Parkinson's disease	0.000875	0.00123	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00086	0.00121	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PENK—Parkinson's disease	0.000857	0.0012	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAG—Parkinson's disease	0.000857	0.0012	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—DRD3—Parkinson's disease	0.000852	0.0012	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HTR7—Parkinson's disease	0.000848	0.00119	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—DRD2—Parkinson's disease	0.000848	0.00119	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PDYN—Parkinson's disease	0.000848	0.00119	CbGpPWpGaD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—Parkinson's disease	0.000841	0.00118	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GFAP—Parkinson's disease	0.000837	0.00118	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FGF20—Parkinson's disease	0.000834	0.00117	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HTR7—Parkinson's disease	0.000832	0.00117	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—DRD2—Parkinson's disease	0.000832	0.00117	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GRM5—Parkinson's disease	0.000828	0.00116	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADORA2A—Parkinson's disease	0.000809	0.00113	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—EDN1—Parkinson's disease	0.000804	0.00113	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GFAP—Parkinson's disease	0.000797	0.00112	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000795	0.00112	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GRM5—Parkinson's disease	0.000788	0.00111	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PDYN—Parkinson's disease	0.000784	0.0011	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000775	0.00109	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—EDN1—Parkinson's disease	0.000771	0.00108	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HTR7—Parkinson's disease	0.00077	0.00108	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—DRD2—Parkinson's disease	0.00077	0.00108	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—INSR—Parkinson's disease	0.000746	0.00105	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GFAP—Parkinson's disease	0.000737	0.00103	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—EDN1—Parkinson's disease	0.000734	0.00103	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GRM5—Parkinson's disease	0.000729	0.00102	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGF20—Parkinson's disease	0.000726	0.00102	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FGB—Parkinson's disease	0.000705	0.00099	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADORA2A—Parkinson's disease	0.000704	0.000988	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HTR2A—Parkinson's disease	0.000704	0.000988	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR1A—Parkinson's disease	0.000702	0.000985	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—EDN1—Parkinson's disease	0.0007	0.000983	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGF20—Parkinson's disease	0.000691	0.00097	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TAC1—Parkinson's disease	0.000691	0.00097	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000679	0.000953	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DRD1—Parkinson's disease	0.000678	0.000951	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000675	0.000947	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADORA2A—Parkinson's disease	0.00067	0.00094	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—EDN1—Parkinson's disease	0.000666	0.000935	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DRD3—Parkinson's disease	0.000656	0.000921	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—INSR—Parkinson's disease	0.00065	0.000912	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000642	0.000901	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGF20—Parkinson's disease	0.000639	0.000897	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADORA2A—Parkinson's disease	0.00062	0.00087	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—INSR—Parkinson's disease	0.000618	0.000868	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—EDN1—Parkinson's disease	0.000617	0.000866	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGB—Parkinson's disease	0.000614	0.000862	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRBK1—Parkinson's disease	0.000613	0.00086	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HTR2A—Parkinson's disease	0.000613	0.00086	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR1A—Parkinson's disease	0.000611	0.000857	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TAC1—Parkinson's disease	0.000601	0.000844	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000594	0.000834	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR7—Parkinson's disease	0.000593	0.000833	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DRD2—Parkinson's disease	0.000593	0.000833	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DRD1—Parkinson's disease	0.00059	0.000828	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGB—Parkinson's disease	0.000584	0.00082	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HTR2A—Parkinson's disease	0.000583	0.000818	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR1A—Parkinson's disease	0.000581	0.000816	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TAC1—Parkinson's disease	0.000573	0.000804	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—INSR—Parkinson's disease	0.000572	0.000803	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DRD3—Parkinson's disease	0.000571	0.000802	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DRD1—Parkinson's disease	0.000561	0.000788	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DRD3—Parkinson's disease	0.000544	0.000763	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGB—Parkinson's disease	0.000541	0.000759	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000539	0.000757	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR1A—Parkinson's disease	0.000538	0.000755	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRBK1—Parkinson's disease	0.000533	0.000749	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TAC1—Parkinson's disease	0.00053	0.000744	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DRD1—Parkinson's disease	0.00052	0.000729	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR7—Parkinson's disease	0.000517	0.000725	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DRD2—Parkinson's disease	0.000517	0.000725	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRBK1—Parkinson's disease	0.000508	0.000713	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DRD3—Parkinson's disease	0.000503	0.000706	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF2—Parkinson's disease	0.000497	0.000698	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DRD2—Parkinson's disease	0.000492	0.00069	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR7—Parkinson's disease	0.000492	0.00069	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF1R—Parkinson's disease	0.000481	0.000675	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EDN1—Parkinson's disease	0.000475	0.000667	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRBK1—Parkinson's disease	0.00047	0.000659	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DRD2—Parkinson's disease	0.000455	0.000639	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR7—Parkinson's disease	0.000455	0.000639	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NGF—Parkinson's disease	0.000437	0.000613	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF2—Parkinson's disease	0.000433	0.000608	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF1R—Parkinson's disease	0.000419	0.000588	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR2A—Parkinson's disease	0.000416	0.000583	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EDN1—Parkinson's disease	0.000414	0.000581	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF2—Parkinson's disease	0.000412	0.000578	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF1R—Parkinson's disease	0.000398	0.000559	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EDN1—Parkinson's disease	0.000394	0.000553	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOE—Parkinson's disease	0.000386	0.000542	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF2—Parkinson's disease	0.000381	0.000535	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NGF—Parkinson's disease	0.00038	0.000533	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF1R—Parkinson's disease	0.000369	0.000517	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EDN1—Parkinson's disease	0.000364	0.000511	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR2A—Parkinson's disease	0.000362	0.000508	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NGF—Parkinson's disease	0.000362	0.000508	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR2A—Parkinson's disease	0.000344	0.000483	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOE—Parkinson's disease	0.000336	0.000472	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NGF—Parkinson's disease	0.000335	0.00047	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—INS—Parkinson's disease	0.00033	0.000463	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOE—Parkinson's disease	0.00032	0.000449	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR2A—Parkinson's disease	0.000319	0.000447	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOE—Parkinson's disease	0.000296	0.000416	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—INS—Parkinson's disease	0.000287	0.000403	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—INS—Parkinson's disease	0.000274	0.000384	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—INS—Parkinson's disease	0.000253	0.000355	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CASP3—Parkinson's disease	0.000246	0.000345	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6—Parkinson's disease	0.000244	0.000343	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK8—Parkinson's disease	0.000226	0.000317	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CASP3—Parkinson's disease	0.000214	0.0003	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6—Parkinson's disease	0.000213	0.000298	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CASP3—Parkinson's disease	0.000204	0.000286	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6—Parkinson's disease	0.000202	0.000284	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK8—Parkinson's disease	0.000197	0.000276	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CASP3—Parkinson's disease	0.000188	0.000264	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6—Parkinson's disease	0.000187	0.000263	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK8—Parkinson's disease	0.000187	0.000263	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK8—Parkinson's disease	0.000173	0.000243	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6—Parkinson's disease	0.000144	0.000202	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6—Parkinson's disease	0.000126	0.000176	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6—Parkinson's disease	0.00012	0.000168	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6—Parkinson's disease	0.000111	0.000155	CbGpPWpGaD
